Michael Mingzhao Xing

Professor

1992 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael Mingzhao Xing is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Thyroid Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
Proto-Oncogene Proteins B-raf Medicine & Life Sciences
Thyroid Gland Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Tumors Chemical Compounds
Methylation Medicine & Life Sciences
Genes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2020

BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma

Kim, K. J., Kim, S. G., Tan, J., Shen, X., Viola, D., Elisei, R., Puxeddu, E., Fugazzola, L., Colombo, C., Jarzab, B., Czarniecka, A., Lam, A. K., Mian, C., Vianello, F., Yip, L., Riesco-Eizaguirre, G., Santisteban, P., O'Neill, C. J., Sywak, M. S., Clifton-Bligh, R. & 3 others, Bendlova, B., Sýkorová, V. & Xing, M., Jan 2020, In : European Journal of Cancer. 124, p. 161-169 9 p.

Research output: Contribution to journalArticle

Decision Making
Mutation
Recurrence
Papillary Thyroid Microcarcinoma
Confidence Intervals

Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer

Cheng, W., Shen, X. & Xing, M., Jan 1 2019, In : PloS one. 14, 10, e0221093.

Research output: Contribution to journalArticle

Open Access
Thyroid Neoplasms
breast neoplasms
Tumors
Breast Neoplasms
Mortality

Entering an Era of Precision Management of Thyroid Cancer

Xing, M. M., Mar 1 2019, In : Endocrinology and Metabolism Clinics of North America. 48, 1, p. xvii-xviii

Research output: Contribution to journalEditorial

Thyroid Neoplasms

Genetic-guided Risk Assessment and Management of Thyroid Cancer

Xing, M. M., Mar 1 2019, In : Endocrinology and Metabolism Clinics of North America. 48, 1, p. 109-124 16 p.

Research output: Contribution to journalReview article

Risk Management
Thyroid Neoplasms
Genetic Markers
Mutation
Genotype

Identification and characterization of two novel oncogenic mTOR mutations

Murugan, A. K., Liu, R. & Xing, M. M., Jan 1 2019, In : Oncogene.

Research output: Contribution to journalArticle

Sirolimus
Mutation
Neoplasms
Melanoma
70-kDa Ribosomal Protein S6 Kinases